BetterLife Pharma (BETRF) EBT (2015 - 2019)

BetterLife Pharma has reported EBT for 5 years, with the latest figure at -$1.4 million in Q2 2019.

• On a quarterly basis, EBT rose 5.68% year-over-year to -$1.4 million in Q2 2019; TTM through Apr 2019 was -$5.8 million, a 259.95% decrease from a year earlier, with the FY2026 full-year figure at -$1.1 million, up 58.68% from the prior year.
• EBT was -$1.4 million for Q2 2019 at BetterLife Pharma, up from -$1.5 million in the prior quarter.
• The five-year high for EBT was $463395.5 in Q1 2018, with the low at -$6.8 million in Q1 2016.
• Average EBT over 5 years is -$1.5 million, with a median of -$1.3 million recorded in 2018.
• The sharpest annual moves came in 2016 and 2018: EBT tumbled 7242.93% in 2016, then soared 155.82% in 2018.
• Over 5 years, EBT stood at $9714.7 in 2015, then sank by 7242.93% to -$693916.0 in 2016, then surged by 62.95% to -$257120.0 in 2017, then tumbled by 501.53% to -$1.5 million in 2018, then increased by 7.67% to -$1.4 million in 2019.
• The last three EBT figures came in at -$1.4 million (Q2 2019), -$1.5 million (Q4 2018), and -$1.3 million (Q3 2018), per Business Quant data.